These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5951743)

  • 1. National Formulary drug admissions policy.
    Feldmann EG
    Am J Pharm Sci Support Public Health; 1966; 138(3):98-103. PubMed ID: 5951743
    [No Abstract]   [Full Text] [Related]  

  • 2. The future of managed care drug formularies.
    Navarro RP
    Med Interface; 1994 Apr; 7(4):62-4. PubMed ID: 10133359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Any willing provider meets the formulary.
    Barrueta A
    Health Syst Rev; 1995; 28(4):20, 22-3. PubMed ID: 10144359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug formulary commentary: an integrated health systems approach.
    Boyer ST
    Pharm Pract Manag Q; 1995 Oct; 15(3):83-5. PubMed ID: 10151716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting formulary pull-through strategies: the role of pharmaceutical manufacturers.
    Navarro RP
    Manag Care Interface; 1999 May; 12(5):84-6. PubMed ID: 10537482
    [No Abstract]   [Full Text] [Related]  

  • 6. Formulary submission process catches on ... slowly.
    Cross M
    Manag Care; 2002 Nov; 11(11):32-6. PubMed ID: 12491856
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug companies crying foul over Medicaid's formulary push.
    Carroll J
    Manag Care; 2002 Nov; 11(11):12-4. PubMed ID: 12491852
    [No Abstract]   [Full Text] [Related]  

  • 8. The changing timetable for the evaluation of new products for formulary consideration.
    Giaquinta D
    Manag Care Interface; 2003 Feb; 16(2):24-5, 28. PubMed ID: 12647522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raising the bar in the formulary decision process.
    Navarro RP
    Manag Care Interface; 1999 Jul; 12(7):51, 54. PubMed ID: 10539501
    [No Abstract]   [Full Text] [Related]  

  • 10. The Academy of Managed Care Pharmacy's format for formulary submission.
    Penna P
    Manag Care Interface; 2001 Jun; 14(6):61-2. PubMed ID: 11432152
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceuticals issue brief: managed care drug formularies: year end report-2002.
    Morgan R; MacEachern L
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-7. PubMed ID: 12856686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weighing the evidence: trends in managed care formulary decision making.
    de Lissovoy G
    J Clin Psychiatry; 2003; 64 Suppl 17():29-32. PubMed ID: 14680425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A formulary for sample closets lessens impact of the sales pitch.
    Clin Resour Manag; 2000 Feb; 1(2):26-7. PubMed ID: 11183280
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PMA (Pharmaceutical Manufacturers Association) finances grassroots coalition to fight changes in Medicaid formularies.
    Gatty B
    Hosp Formul; 1993 Aug; 28(8):714, 713. PubMed ID: 10127749
    [No Abstract]   [Full Text] [Related]  

  • 16. Sen. Pryor's formulary plan attacked by drug industry; other groups are less hostile.
    Wagner L
    Mod Healthc; 1990 Apr; 20(14):22. PubMed ID: 10106496
    [No Abstract]   [Full Text] [Related]  

  • 17. Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitors.
    Wang YR; Pauly MV
    Manag Care Interface; 2005 Aug; 18(8):39-45. PubMed ID: 16127891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managed care guidelines for the economic evaluation of pharmaceuticals.
    Langley PC; Martin RE
    Am J Manag Care; 1997 Jul; 3(7):1013-21. PubMed ID: 10173366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCI Launches Drug Formulary.
    Cancer Discov; 2017 Mar; 7(3):240-241. PubMed ID: 28126712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality drugs and the Saskatchewan formulary.
    Johnson GE
    Can J Hosp Pharm; 1975; 28(3):84-6. PubMed ID: 10316621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.